Publikasjoner for deg som jobber med sjeldne sykdommer som f.eks. PKU, MSUD, eller fettsyreoksidasjonsdefekter

Publikasjoner for deg som jobber med sjeldne sykdommer som f.eks. PKU, MSUD, eller fettsyreoksidasjonsdefekter

PKU MSUD TYR GA1 GMP HCU IVA MMA/PA Fettsyreoksidasjonsdefekter

PKU

Breaking Barriers: Stakeholder Insights into Physical Activity, Exercise, and Dietary Behaviours Among Individuals with Phenylketonuria (PKU)

European guidelines on diagnosis and treatment of phenylketonuria: First revision

Rethinking phenylalanine levels in phenylketonuria for optimal neurocognitive development beyond childhood

Phenylketonuria—Past, Present, and Future Directions

Nutritional Practices and Knowledge of Patients with Phenylketonuria

Advances in Phenylketonuria (PKU) Nutrition and Diet Research (2nd Edition)

Protein Substitutes in PKU; Their Historical Evolution

Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU

Casein glycomacropeptide in phenylketonuria: does it bring clinical benefit?

Global considerations for lifelong management and therapeutic development for phenylketonuria

Longitudinal Dietary Intake Data in Patients with Phenylketonuria from Europe: The Impact of Age and Phenylketonuria Severity

Phenylalanine Tolerance over Time in Phenylketonuria: A Systematic Review and Meta-Analysis

MSUD

Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach

TYR

Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines

GA1

Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: Third revision

GMP

Global Use of Casein Glycomacropeptide Protein Substitutes for Phenylketonuria (PKU): Health Professional Perspectives

Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU

Casein glycomacropeptide in phenylketonuria: does it bring clinical benefit?

Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I

The effects of casein glycomacropeptide on general health status in children with PKU: A randomized crossover trial

Protein substitutes used in the treatment of phenylketonuria distinctly modulate gut nutrient absorption and bacterial growth: An in vitro study

Relatert innhold

Metabolske sykdommer materiell

Last ned vårt brosjyremateriell og finn mer informasjon

Bestillingsinformasjon

For spørsmål om metabolske sykdommer hos Nutricia, vennligst kontakt Ellen Bratlie

Ellen Bratlie

Category Manager, Metabolics & Ketogenics

ellen.bratlie@danone.com 90 17 71 21